August 17, 2025VirusesOpen Access

Updates on Recent Advancements in Hepatitis D Virus Treatment

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review highlights recent improvements in hepatitis D virus treatment, including new drugs like bulevirtide, indicating better options available.

Bulevirtide is the first approved treatment for chronic hepatitis D virus infection, improving options for patients with limited choices.
Pegylated interferon-α serves as the primary therapy for chronic HDV, but it has limited effectiveness and significant side effects.
Recent developments in therapies address the need for more effective treatments for hepatitis D virus infection among hepatitis B patients.
Continued research is vital for finding alternative treatments for chronic HDV to reduce disease progression and improve patient outcomes.

Bardak et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Review highlights recent improvements in hepatitis D virus treatment, including new drugs like bulevirtide, indicating better options available.